Current therapy of Wilms' tumor
- Arthur M Smith,
- J. Priestley,
- P. Tomashefsky,
- M. Tannenbaum,
- J. Lattimer
- ,
- New York Presbyterian Hospital
Scholary Output:
Contribution to journal
Article
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Whereas as recently as ten years ago most children with Wilms' tumor died, today even children initially presenting with symptoms and signs of advanced metastatic disease have a chance for survival. Basic studies on a naturally occurring tumor in rats, which is quite similar to human Wilms' tumor both morphologically and pathophysiologically, have demonstrated the clear cut therapeutic advantage of the combination of actinomycin D and irradiation on this disease process. These results can be directly translated into the success story that has been seen in the clinical management of human Wilms' tumor. Further research remains to be done concerning the immunologic aspects of Wilms' tumor activity.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 1652-1656 (5 pages)Journal (Volume, Issue Number)
New York State Journal of Medicine (Volume 73, Issue 12)Publication milestones
- Published - 12/01/1973
Publication status
Published - 12/01/1973
ISSN
0028-7628Publication IDs
- Scopus: 0015876352
- PubMed: 4350908
Access to documents
Publication metrics
Metrics
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
PlumX
Citation count
1
